Ziopharm Oncology (ZIOP) Reports Q3 Loss of $0.14/Share

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/3/2026

1. AAPL
2. PLTR
3. CRWD
4. RXRX
5. ON
6. VRTX
7. INSP
8. CVI
9. CHKP
10. MPC

Go back to Ziopharm Oncology (ZIOP) Reports Q3 Loss of $0.14/Share

ZIOPHARM Reports Third-Quarter 2015 Financial Results and Recent Activities

November 2, 2015 4:05 PM EST

BOSTON, Nov. 2, 2015 (GLOBE NEWSWIRE) -- ZIOPHARM Oncology, Inc. (Nasdaq: ZIOP) today announced financial results for the third quarter ended September 30, 2015, and provided an update on the company's recent activities.

"The third quarter saw an important expansion of our pipeline with the signing of a new Exclusive Channel Collaboration with our longtime partner Intrexon to include immunotherapies for the treatment of graft-versus-host-disease, or GvHD," said Laurence Cooper, M.D., Ph.D., Chief Executive Officer of ZIOPHARM. "This adds to our research programs with Intrexon in virotherapies, T-cell therapies and natural killer cell... More